JAZZ
Jazz Pharmaceuticals plc
Stock
$235.67+2.66 (+1.14%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $1.8B
- YoY, 2025
- +30.6%
- 5-year CAGR
- +16.2%
- 10-year CAGR
- +15.0%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $1.8B | +30.6% |
| 2024 | $1.4B | +3.1% |
| 2023 | $1.3B | −5.2% |
| 2022 | $1.4B | −2.4% |
| 2021 | $1.5B | +69.9% |
| 2020 | $854M | +15.9% |
| 2019 | $737M | +7.8% |
| 2018 | $684M | +25.6% |
| 2017 | $544M | +8.2% |
| 2016 | $503M | +12.0% |
| 2015 | $449M | +10.6% |
| 2014 | $406M | +33.5% |
| 2013 | $304M | +35.9% |
| 2012 | $224M | +105.5% |
| 2011 | $109M | +57.9% |
| 2010 | $69M | +17.6% |
| 2009 | $59M | — |